Report Detail

Request for Sample of this report

Pharma & Healthcare Global and United States Oral Mucositis Drugs for Cancer Therapy Market Report & Forecast 2022-2028

  • RnM4424841
    • |
  • 22 April, 2022
    • |
  • Global
    • |
  • 104 Pages
    • |
  • QYResearch
    • |
  • Pharma & Healthcare

Summary:

Oral mucositis is the most common complication of chemotherapy, and occurs usually in the people suffering from head and neck cancer. It causes damage to mucosal lining of the mouth which results in formation of ulcers and infections. The disease occurs usually occurs after 5 to 10 days of a chemotherapy process in cancer patients. Oral mucositis leads to different problems such as severe pain in mouth, lack of nutrition due to inability to eat, increased risk of infections due to open sores in the oral cavity. The disease usually lasts for one week to six weeks or more.
Market Analysis and Insights: Global and United States Oral Mucositis Drugs for Cancer Therapy Market
This report focuses on global and United States Oral Mucositis Drugs for Cancer Therapy market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Oral Mucositis Drugs for Cancer Therapy market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Mouthwash accounting for % of the Oral Mucositis Drugs for Cancer Therapy global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Chemotherapy was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Oral Mucositis Drugs for Cancer Therapy market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
Global Oral Mucositis Drugs for Cancer Therapy Scope and Market Size
Oral Mucositis Drugs for Cancer Therapy market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Oral Mucositis Drugs for Cancer Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Oral Mucositis Drugs for Cancer Therapy market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type, the Oral Mucositis Drugs for Cancer Therapy market is segmented into
Mouthwash
Pain Control Medication
Other
Segment by Application, the Oral Mucositis Drugs for Cancer Therapy market is segmented into
Chemotherapy
Radiotherapy
Regional and Country-level Analysis
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Landscape and Oral Mucositis Drugs for Cancer Therapy Market Share Analysis
Oral Mucositis Drugs for Cancer Therapy market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Oral Mucositis Drugs for Cancer Therapy business, the date to enter into the Oral Mucositis Drugs for Cancer Therapy market, Oral Mucositis Drugs for Cancer Therapy product introduction, recent developments, etc.
The major vendors covered:
3M Healthcare
GSK
Pfizer
Colgate-Palmolive
Norgine
Sobi
Bausch Health
EUSA Pharma
Camurus
Clinigen Group
Helsinn Healthcare
Alliance Pharma


Table of Contents

    1 Study Coverage

    • 1.1 Oral Mucositis Drugs for Cancer Therapy Product Introduction
    • 1.2 Global Oral Mucositis Drugs for Cancer Therapy Outlook 2017 VS 2022 VS 2028
      • 1.2.1 Global Oral Mucositis Drugs for Cancer Therapy Sales in US$ Million for the Year 2017-2028
      • 1.2.2 Global Oral Mucositis Drugs for Cancer Therapy Sales in Volume for the Year 2017-2028
    • 1.3 United States Oral Mucositis Drugs for Cancer Therapy Outlook 2017 VS 2022 VS 2028
      • 1.3.1 United States Oral Mucositis Drugs for Cancer Therapy Sales in US$ Million for the Year 2017-2028
      • 1.3.2 United States Oral Mucositis Drugs for Cancer Therapy Sales in Volume for the Year 2017-2028
    • 1.4 Oral Mucositis Drugs for Cancer Therapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
      • 1.4.1 The Market Share of United States Oral Mucositis Drugs for Cancer Therapy in Global, 2017 VS 2022 VS 2028
      • 1.4.2 The Growth Rate of Oral Mucositis Drugs for Cancer Therapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
    • 1.5 Oral Mucositis Drugs for Cancer Therapy Market Dynamics
      • 1.5.1 Oral Mucositis Drugs for Cancer Therapy Industry Trends
      • 1.5.2 Oral Mucositis Drugs for Cancer Therapy Market Drivers
      • 1.5.3 Oral Mucositis Drugs for Cancer Therapy Market Challenges
      • 1.5.4 Oral Mucositis Drugs for Cancer Therapy Market Restraints
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Market by Type

    • 2.1 Oral Mucositis Drugs for Cancer Therapy Market Segment by Type
      • 2.1.1 Mouthwash
      • 2.1.2 Pain Control Medication
      • 2.1.3 Other
    • 2.2 Global Oral Mucositis Drugs for Cancer Therapy Market Size by Type
      • 2.2.1 Global Oral Mucositis Drugs for Cancer Therapy Sales in Value, by Type (2017, 2022 & 2028)
      • 2.2.2 Global Oral Mucositis Drugs for Cancer Therapy Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.2.3 Global Oral Mucositis Drugs for Cancer Therapy Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    • 2.3 United States Oral Mucositis Drugs for Cancer Therapy Market Size by Type
      • 2.3.1 United States Oral Mucositis Drugs for Cancer Therapy Sales in Value, by Type (2017, 2022 & 2028)
      • 2.3.2 United States Oral Mucositis Drugs for Cancer Therapy Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.3.3 United States Oral Mucositis Drugs for Cancer Therapy Average Selling Price (ASP) by Type (2017, 2022 & 2028)

    3 Market by Application

    • 3.1 Oral Mucositis Drugs for Cancer Therapy Market Segment by Application
      • 3.1.1 Chemotherapy
      • 3.1.2 Radiotherapy
    • 3.2 Global Oral Mucositis Drugs for Cancer Therapy Market Size by Application
      • 3.2.1 Global Oral Mucositis Drugs for Cancer Therapy Sales in Value, by Application (2017, 2022 & 2028)
      • 3.2.2 Global Oral Mucositis Drugs for Cancer Therapy Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 Global Oral Mucositis Drugs for Cancer Therapy Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    • 3.3 United States Oral Mucositis Drugs for Cancer Therapy Market Size by Application
      • 3.3.1 United States Oral Mucositis Drugs for Cancer Therapy Sales in Value, by Application (2017, 2022 & 2028)
      • 3.3.2 United States Oral Mucositis Drugs for Cancer Therapy Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 United States Oral Mucositis Drugs for Cancer Therapy Average Selling Price (ASP) by Application (2017, 2022 & 2028)

    4 Global Oral Mucositis Drugs for Cancer Therapy Competitor Landscape by Company

    • 4.1 Global Oral Mucositis Drugs for Cancer Therapy Market Size by Company
      • 4.1.1 Top Global Oral Mucositis Drugs for Cancer Therapy Manufacturers Ranked by Revenue (2021)
      • 4.1.2 Global Oral Mucositis Drugs for Cancer Therapy Revenue by Manufacturer (2017-2022)
      • 4.1.3 Global Oral Mucositis Drugs for Cancer Therapy Sales by Manufacturer (2017-2022)
      • 4.1.4 Global Oral Mucositis Drugs for Cancer Therapy Price by Manufacturer (2017-2022)
    • 4.2 Global Oral Mucositis Drugs for Cancer Therapy Concentration Ratio (CR)
      • 4.2.1 Oral Mucositis Drugs for Cancer Therapy Market Concentration Ratio (CR) (2017-2022)
      • 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Oral Mucositis Drugs for Cancer Therapy in 2021
      • 4.2.3 Global Oral Mucositis Drugs for Cancer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.3 Global Oral Mucositis Drugs for Cancer Therapy Manufacturing Base Distribution, Product Type
      • 4.3.1 Global Oral Mucositis Drugs for Cancer Therapy Manufacturers, Headquarters and Distribution of Producing Region
      • 4.3.2 Manufacturers Oral Mucositis Drugs for Cancer Therapy Product Type
      • 4.3.3 Date of International Manufacturers Enter into Oral Mucositis Drugs for Cancer Therapy Market
    • 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 4.5 United States Oral Mucositis Drugs for Cancer Therapy Market Size by Company
      • 4.5.1 Top Oral Mucositis Drugs for Cancer Therapy Players in United States, Ranked by Revenue (2021)
      • 4.5.2 United States Oral Mucositis Drugs for Cancer Therapy Revenue by Players (2020, 2021 & 2022)
      • 4.5.3 United States Oral Mucositis Drugs for Cancer Therapy Sales by Players (2020, 2021 & 2022)

    5 Global Oral Mucositis Drugs for Cancer Therapy Market Size by Region

    • 5.1 Global Oral Mucositis Drugs for Cancer Therapy Market Size by Region: 2017 VS 2022 VS 2028
    • 5.2 Global Oral Mucositis Drugs for Cancer Therapy Market Size in Volume by Region (2017-2028)
      • 5.2.1 Global Oral Mucositis Drugs for Cancer Therapy Sales in Volume by Region: 2017-2022
      • 5.2.2 Global Oral Mucositis Drugs for Cancer Therapy Sales in Volume Forecast by Region (2023-2028)
    • 5.3 Global Oral Mucositis Drugs for Cancer Therapy Market Size in Value by Region (2017-2028)
      • 5.3.1 Global Oral Mucositis Drugs for Cancer Therapy Sales in Value by Region: 2017-2022
      • 5.3.2 Global Oral Mucositis Drugs for Cancer Therapy Sales in Value by Region: 2023-2028

    6 Segment in Region Level & Country Level

    • 6.1 North America
      • 6.1.1 North America Oral Mucositis Drugs for Cancer Therapy Market Size YoY Growth 2017-2028
      • 6.1.2 North America Oral Mucositis Drugs for Cancer Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.1.3 United States
      • 6.1.4 Canada
    • 6.2 Asia-Pacific
      • 6.2.1 Asia-Pacific Oral Mucositis Drugs for Cancer Therapy Market Size YoY Growth 2017-2028
      • 6.2.2 Asia-Pacific Oral Mucositis Drugs for Cancer Therapy Market Facts & Figures by Region (2017, 2022 & 2028)
      • 6.2.3 China
      • 6.2.4 Japan
      • 6.2.5 South Korea
      • 6.2.6 India
      • 6.2.7 Australia
      • 6.2.8 China Taiwan
      • 6.2.9 Indonesia
      • 6.2.10 Thailand
      • 6.2.11 Malaysia
    • 6.3 Europe
      • 6.3.1 Europe Oral Mucositis Drugs for Cancer Therapy Market Size YoY Growth 2017-2028
      • 6.3.2 Europe Oral Mucositis Drugs for Cancer Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.3.3 Germany
      • 6.3.4 France
      • 6.3.5 U.K.
      • 6.3.6 Italy
      • 6.3.7 Russia
    • 6.4 Latin America
      • 6.4.1 Latin America Oral Mucositis Drugs for Cancer Therapy Market Size YoY Growth 2017-2028
      • 6.4.2 Latin America Oral Mucositis Drugs for Cancer Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.4.3 Mexico
      • 6.4.4 Brazil
      • 6.4.5 Argentina
      • 6.4.6 Colombia
    • 6.5 Middle East and Africa
      • 6.5.1 Middle East and Africa Oral Mucositis Drugs for Cancer Therapy Market Size YoY Growth 2017-2028
      • 6.5.2 Middle East and Africa Oral Mucositis Drugs for Cancer Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.5.3 Turkey
      • 6.5.4 Saudi Arabia
      • 6.5.5 UAE

    7 Company Profiles

    • 7.1 3M Healthcare
      • 7.1.1 3M Healthcare Corporation Information
      • 7.1.2 3M Healthcare Description and Business Overview
      • 7.1.3 3M Healthcare Oral Mucositis Drugs for Cancer Therapy Sales, Revenue and Gross Margin (2017-2022)
      • 7.1.4 3M Healthcare Oral Mucositis Drugs for Cancer Therapy Products Offered
      • 7.1.5 3M Healthcare Recent Development
    • 7.2 GSK
      • 7.2.1 GSK Corporation Information
      • 7.2.2 GSK Description and Business Overview
      • 7.2.3 GSK Oral Mucositis Drugs for Cancer Therapy Sales, Revenue and Gross Margin (2017-2022)
      • 7.2.4 GSK Oral Mucositis Drugs for Cancer Therapy Products Offered
      • 7.2.5 GSK Recent Development
    • 7.3 Pfizer
      • 7.3.1 Pfizer Corporation Information
      • 7.3.2 Pfizer Description and Business Overview
      • 7.3.3 Pfizer Oral Mucositis Drugs for Cancer Therapy Sales, Revenue and Gross Margin (2017-2022)
      • 7.3.4 Pfizer Oral Mucositis Drugs for Cancer Therapy Products Offered
      • 7.3.5 Pfizer Recent Development
    • 7.4 Colgate-Palmolive
      • 7.4.1 Colgate-Palmolive Corporation Information
      • 7.4.2 Colgate-Palmolive Description and Business Overview
      • 7.4.3 Colgate-Palmolive Oral Mucositis Drugs for Cancer Therapy Sales, Revenue and Gross Margin (2017-2022)
      • 7.4.4 Colgate-Palmolive Oral Mucositis Drugs for Cancer Therapy Products Offered
      • 7.4.5 Colgate-Palmolive Recent Development
    • 7.5 Norgine
      • 7.5.1 Norgine Corporation Information
      • 7.5.2 Norgine Description and Business Overview
      • 7.5.3 Norgine Oral Mucositis Drugs for Cancer Therapy Sales, Revenue and Gross Margin (2017-2022)
      • 7.5.4 Norgine Oral Mucositis Drugs for Cancer Therapy Products Offered
      • 7.5.5 Norgine Recent Development
    • 7.6 Sobi
      • 7.6.1 Sobi Corporation Information
      • 7.6.2 Sobi Description and Business Overview
      • 7.6.3 Sobi Oral Mucositis Drugs for Cancer Therapy Sales, Revenue and Gross Margin (2017-2022)
      • 7.6.4 Sobi Oral Mucositis Drugs for Cancer Therapy Products Offered
      • 7.6.5 Sobi Recent Development
    • 7.7 Bausch Health
      • 7.7.1 Bausch Health Corporation Information
      • 7.7.2 Bausch Health Description and Business Overview
      • 7.7.3 Bausch Health Oral Mucositis Drugs for Cancer Therapy Sales, Revenue and Gross Margin (2017-2022)
      • 7.7.4 Bausch Health Oral Mucositis Drugs for Cancer Therapy Products Offered
      • 7.7.5 Bausch Health Recent Development
    • 7.8 EUSA Pharma
      • 7.8.1 EUSA Pharma Corporation Information
      • 7.8.2 EUSA Pharma Description and Business Overview
      • 7.8.3 EUSA Pharma Oral Mucositis Drugs for Cancer Therapy Sales, Revenue and Gross Margin (2017-2022)
      • 7.8.4 EUSA Pharma Oral Mucositis Drugs for Cancer Therapy Products Offered
      • 7.8.5 EUSA Pharma Recent Development
    • 7.9 Camurus
      • 7.9.1 Camurus Corporation Information
      • 7.9.2 Camurus Description and Business Overview
      • 7.9.3 Camurus Oral Mucositis Drugs for Cancer Therapy Sales, Revenue and Gross Margin (2017-2022)
      • 7.9.4 Camurus Oral Mucositis Drugs for Cancer Therapy Products Offered
      • 7.9.5 Camurus Recent Development
    • 7.10 Clinigen Group
      • 7.10.1 Clinigen Group Corporation Information
      • 7.10.2 Clinigen Group Description and Business Overview
      • 7.10.3 Clinigen Group Oral Mucositis Drugs for Cancer Therapy Sales, Revenue and Gross Margin (2017-2022)
      • 7.10.4 Clinigen Group Oral Mucositis Drugs for Cancer Therapy Products Offered
      • 7.10.5 Clinigen Group Recent Development
    • 7.11 Helsinn Healthcare
      • 7.11.1 Helsinn Healthcare Corporation Information
      • 7.11.2 Helsinn Healthcare Description and Business Overview
      • 7.11.3 Helsinn Healthcare Oral Mucositis Drugs for Cancer Therapy Sales, Revenue and Gross Margin (2017-2022)
      • 7.11.4 Helsinn Healthcare Oral Mucositis Drugs for Cancer Therapy Products Offered
      • 7.11.5 Helsinn Healthcare Recent Development
    • 7.12 Alliance Pharma
      • 7.12.1 Alliance Pharma Corporation Information
      • 7.12.2 Alliance Pharma Description and Business Overview
      • 7.12.3 Alliance Pharma Oral Mucositis Drugs for Cancer Therapy Sales, Revenue and Gross Margin (2017-2022)
      • 7.12.4 Alliance Pharma Products Offered
      • 7.12.5 Alliance Pharma Recent Development

    8 Industry Chain and Sales Channels Analysis

    • 8.1 Oral Mucositis Drugs for Cancer Therapy Industry Chain Analysis
    • 8.2 Oral Mucositis Drugs for Cancer Therapy Key Raw Materials
      • 8.2.1 Key Raw Materials
      • 8.2.2 Oral Mucositis Drugs for Cancer Therapy Distributors
    • 8.3 Oral Mucositis Drugs for Cancer Therapy Production Mode & Process
    • 8.4 Oral Mucositis Drugs for Cancer Therapy Sales and Marketing
      • 8.4.1 Oral Mucositis Drugs for Cancer Therapy Sales Channels
      • 8.4.2 Oral Mucositis Drugs for Cancer Therapy Distributors
    • 8.5 Oral Mucositis Drugs for Cancer Therapy Customers

    9 Research Findings and Conclusion

      10 Appendix

      • 10.1 Research Methodology
        • 10.1.1 Methodology/Research Approach
        • 10.1.2 Data Source
      • 10.2 Author Details

      Summary:
      Get latest Market Research Reports on Oral Mucositis Drugs for Cancer Therapy. Industry analysis & Market Report on Oral Mucositis Drugs for Cancer Therapy is a syndicated market report, published as Global and United States Oral Mucositis Drugs for Cancer Therapy Market Report & Forecast 2022-2028. It is complete Research Study and Industry Analysis of Oral Mucositis Drugs for Cancer Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,850.00
      		$7,700.00
      		2,968.35
      		5,936.70
      		3,565.10
      		7,130.20
      		589,974.00
      		1,179,948.00
      		324,670.50
      		649,341.00
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo